IgG/IgM RATIO FOR DETERMINING EFFECTIVENESS OF INTERFERON THERAPY IN INDIVIDUALS WITH HCV INFECTIONS

摘要

A means for determining the effectiveness of interferon therapy for individuals receiving such therapy for HCV infections. Assaying for the presence of anti-HCV IgG and anti-HCV IgM and determining a ratio of the pre-interferon therapy amount of anti-HCV IgG to the pre-interferon therapy amount of anti-HCV IgM provide means for indicating the likelihood of an individual's response to interferon therapy.